Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Leading angel networks in Oxford merge to catalyse early-stage tech investment in the Oxford Cluster.
Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.
Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
Osage University Partners and Oxford University Innovation sign MoU on investment into Oxford University spinouts.
Oxford University, Sensyne Health, Evotec, and OSI create new partnership called LAB10x to accelerate data-driven drug discovery powered by AI
LAB10x aims to accelerate the commercialisation of the next generation of digital therapeutics and data-driven drug discovery from clinical artificial intelligence research and digital health innovations at Oxford University
The Oxford University spinout secures investment from Centrica Innovations to support growth.
Development of a vaccine candidate with potential to save millions worldwide will be accelerated in commercialisation deal with Blue Water Vaccines.